Module

Timing and Choice of Therapy in Treatment-Naive Patients

Source: HIV/AIDS Annual Update 2007

Timing and Choice of Therapy in Treatment-Naive Patients


Faculty:

  • Roy M. Gulick, MD, MPH

CME CREDIT INFORMATION

Release Date: 07/26/07

Expiration Date: 07/25/08


Physicians: maximum of 1.5 AMA PRA Category 1 Credit(s)

Pharmacists: 1.4 contact hours (0.14 CEUs)

Registered Nurses: 1.4 Nursing CE credits

Status: Please log in to view status



Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss the most appropriate timing for the initiation of antiretroviral treatment
  • Identify antiretroviral therapy approaches for treatment-naive HIV-infected patients
  • Describe future potential developments in standardized ART

Topics covered include:

  • Introduction
  • Initiation of Therapy
  • Treatment Guidelines for First-Line Therapy
  • Transmitted Resistance and the Initiation of Therapy
  • Dual-NRTI Combinations for Initial Therapy
  • NNRTIs
  • PIs
  • NNRTI-Based vs PI-Based Regimens
  • Additional Strategies
  • Summary: Implications for Clinical Practice


Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Educational grants provided by:

Educational grants support only the CME-certified components of this program.